Changes in UK drug-pricing scheme could impede access, group warns

05/8/2013 | PharmaTimes (U.K.)

A U.K. government proposal to use value-based pricing for pharmaceuticals could make it more difficult for patients to afford treatment, think tank 2020health says in a new report. The group calls for allowing drug companies to set their own prices and adjust old drug prices to ensure affordability.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Chicago, IL
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC